TY - JOUR AU - Desbois, A. C. AU - Cacoub, P. PY - 2016 DA - 2016// TI - Systemic sclerosis: an update in 2016 JO - Autoimmun Rev VL - 15 UR - https://doi.org/10.1016/j.autrev.2016.01.007 DO - 10.1016/j.autrev.2016.01.007 ID - Desbois2016 ER - TY - JOUR AU - Walker, U. A. AU - Tyndall, A. AU - Czirják, L. AU - Denton, C. AU - Farge-Bancel, D. AU - Kowal-Bielecka, O. AU - Müller-Ladner, U. AU - Bocelli-Tyndall, C. AU - Matucci-Cerinic, M. PY - 2007 DA - 2007// TI - Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.062901 DO - 10.1136/ard.2006.062901 ID - Walker2007 ER - TY - BOOK AU - Mayes, M. D. PY - 1999 DA - 1999// TI - The scleroderma book: a guide for patients and families PB - Oxford University Press CY - New York ID - Mayes1999 ER - TY - JOUR AU - Steen, V. D. PY - 1998 DA - 1998// TI - Clinical manifestations of systemic sclerosis JO - Semin Cutan Med Surg VL - 17 UR - https://doi.org/10.1016/S1085-5629(98)80062-X DO - 10.1016/S1085-5629(98)80062-X ID - Steen1998 ER - TY - JOUR AU - Connolly, M. K. PY - 2001 DA - 2001// TI - Scleroderma JO - Dermatol Ther VL - 14 UR - https://doi.org/10.1046/j.1529-8019.2001.014002081.x DO - 10.1046/j.1529-8019.2001.014002081.x ID - Connolly2001 ER - TY - JOUR AU - Razykov, I. AU - Thombs, B. D. AU - Hudson, M. PY - 2009 DA - 2009// TI - Prevalence and clinical correlates of pruritus in patients with systemic sclerosis JO - Arthritis Care Res VL - 61 UR - https://doi.org/10.1002/art.25010 DO - 10.1002/art.25010 ID - Razykov2009 ER - TY - JOUR AU - Hebbar, M. AU - Gillot, J. M. AU - Hachulla, E. AU - Lassalle, P. AU - Hatron, P. Y. AU - Devulder, B. AU - Janin, A. PY - 1996 DA - 1996// TI - Early expression of E-selectin, tumor necrosis factor alpha, and mast cell infiltration in the salivary glands of patients with systemic sclerosis JO - Arthritis Rheum VL - 39 UR - https://doi.org/10.1002/art.1780390713 DO - 10.1002/art.1780390713 ID - Hebbar1996 ER - TY - JOUR AU - Hügle, T. AU - Hogan, V. AU - White, K. E. AU - Laar, J. M. PY - 2011 DA - 2011// TI - Mast cells are a source of transforming growth factor β in systemic sclerosis JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30190 DO - 10.1002/art.30190 ID - Hügle2011 ER - TY - JOUR AU - Irani, A. M. AU - Gruber, B. L. AU - Kaufman, L. D. AU - Kahaleh, M. B. AU - Schwartz, L. B. PY - 1992 DA - 1992// TI - Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation JO - Arthritis Rheum VL - 35 UR - https://doi.org/10.1002/art.1780350813 DO - 10.1002/art.1780350813 ID - Irani1992 ER - TY - JOUR AU - Akimoto, S. AU - Ishikawa, O. AU - Igarashi, Y. AU - Kurosawa, M. AU - Miyachi, Y. PY - 1998 DA - 1998// TI - Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation JO - Br J Dermatol VL - 138 UR - https://doi.org/10.1046/j.1365-2133.1998.02114.x DO - 10.1046/j.1365-2133.1998.02114.x ID - Akimoto1998 ER - TY - JOUR AU - Onishi, A. AU - Sugiyama, D. AU - Kumagai, S. AU - Morinobu, A. PY - 2013 DA - 2013// TI - Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies JO - Arthritis Rheum VL - 65 UR - https://doi.org/10.1002/art.37969 DO - 10.1002/art.37969 ID - Onishi2013 ER - TY - JOUR AU - Olesen, A. B. AU - Svaerke, C. AU - Farkas, D. K. AU - Sørensen, H. T. PY - 2010 DA - 2010// TI - Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study JO - Br J Dermatol VL - 163 UR - https://doi.org/10.1111/j.1365-2133.2010.09861.x DO - 10.1111/j.1365-2133.2010.09861.x ID - Olesen2010 ER - TY - JOUR AU - Kuo, C. F. AU - Luo, S. F. AU - Yu, K. H. AU - Chou, I. J. AU - Tseng, W. Y. AU - Chang, H. C. AU - Fang, Y. F. AU - Chiou, M. J. AU - See, L. C. PY - 2012 DA - 2012// TI - Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan JO - Scand J Rheumatol VL - 41 UR - https://doi.org/10.3109/03009742.2011.618145 DO - 10.3109/03009742.2011.618145 ID - Kuo2012 ER - TY - JOUR AU - Frigui, M. AU - Dupin, N. AU - Carlotti, A. AU - Bussone, G. AU - Pestre, V. AU - Charles, P. AU - Crabol, Y. AU - Bérezné, A. AU - Guillevin, L. AU - Mouthon, L. PY - 2013 DA - 2013// TI - Telangiectasic mastocytosis with systemic sclerosis JO - Presse Med VL - 42 UR - https://doi.org/10.1016/j.lpm.2012.10.014 DO - 10.1016/j.lpm.2012.10.014 ID - Frigui2013 ER - TY - JOUR AU - Bagnato, G. AU - Harari, S. PY - 2015 DA - 2015// TI - Cellular interactions in the pathogenesis of interstitial lung diseases JO - Eur Respir Rev VL - 24 UR - https://doi.org/10.1183/09059180.00003214 DO - 10.1183/09059180.00003214 ID - Bagnato2015 ER - TY - JOUR AU - Yukawa, S. AU - Yamaoka, K. AU - Sawamukai, N. AU - Shimajiri, S. AU - Saito, K. AU - Tanaka, Y. PY - 2010 DA - 2010// TI - Involvement of mast cells in systemic sclerosis JO - Nihon Rinsho Meneki Gakkai Kaishi. VL - 33 UR - https://doi.org/10.2177/jsci.33.81 DO - 10.2177/jsci.33.81 ID - Yukawa2010 ER - TY - JOUR AU - Yukawa, S. AU - Yamaoka, K. AU - Sawamukai, N. AU - Shimajiri, S. AU - Kubo, S. AU - Miyagawa, I. AU - Sonomoto, K. AU - Saito, K. AU - Tanaka, Y. PY - 2013 DA - 2013// TI - Dermal mast cell density in fingers reflects severity of skin sclerosis in systemic sclerosis JO - Mod Rheumatol VL - 23 UR - https://doi.org/10.3109/s10165-012-0813-8 DO - 10.3109/s10165-012-0813-8 ID - Yukawa2013 ER - TY - JOUR AU - Akimoto, S. AU - Ishikawa, O. AU - Igarashi, Y. AU - Kurosawa, M. AU - Miyachi, Y. PY - 1998 DA - 1998// TI - Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation JO - Br J Dermatol VL - 138 UR - https://doi.org/10.1046/j.1365-2133.1998.02114.x DO - 10.1046/j.1365-2133.1998.02114.x ID - Akimoto1998 ER - TY - JOUR AU - Hügle, T. AU - Hogan, V. AU - White, K. E. AU - Laar, J. M. PY - 2011 DA - 2011// TI - Mast cells are a source of transforming growth factor β in systemic sclerosis JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30190 DO - 10.1002/art.30190 ID - Hügle2011 ER - TY - JOUR AU - Hügle, T. PY - 2014 DA - 2014// TI - Beyond allergy: the role of mast cells in fibrosis JO - Swiss Med Wkly. VL - 3 ID - Hügle2014 ER - TY - JOUR AU - Vega-Ruiz, A. AU - Cortes, J. E. AU - Sever, M. AU - Manshouri, T. AU - Quintás-Cardama, A. AU - Luthra, R. AU - Kantarjian, H. M. AU - Verstovsek, S. PY - 2009 DA - 2009// TI - Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis JO - Leuk Res VL - 33 UR - https://doi.org/10.1016/j.leukres.2008.12.020 DO - 10.1016/j.leukres.2008.12.020 ID - Vega-Ruiz2009 ER - TY - JOUR AU - Denton, C. P. AU - Merkel, P. A. AU - Furst, D. E. AU - Khanna, D. AU - Emery, P. AU - Hsu, V. M. AU - Silliman, N. AU - Streisand, J. AU - Powell, J. AU - Akesson, A. AU - Coppock, J. PY - 2007 DA - 2007// TI - Cat-192 Study Group; Scleroderma Clinical Trials Consortium. Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192 JO - Arthritis Rheum VL - 56 UR - https://doi.org/10.1002/art.22289 DO - 10.1002/art.22289 ID - Denton2007 ER - TY - JOUR AU - Akhmetshina, A. AU - Venalis, P. AU - Dees, C. AU - Busch, N. AU - Zwerina, J. AU - Schett, G. AU - Distler, O. AU - Distler, J. H. PY - 2009 DA - 2009// TI - Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis JO - Arthritis Rheum VL - 60 UR - https://doi.org/10.1002/art.24186 DO - 10.1002/art.24186 ID - Akhmetshina2009 ER - TY - JOUR AU - Fraticelli, P. AU - Gabrielli, B. AU - Pomponio, G. AU - Valentini, G. AU - Bosello, S. AU - Riboldi, P. AU - Gerosa, M. AU - Faggioli, P. AU - Giacomelli, R. AU - Del, P. a. p. a. N. AU - Gerli, R. AU - Lunardi, C. AU - Bombardieri, S. AU - Malorni, W. AU - Corvetta, A. AU - Gabrielli, A. AU - Moroncini, G. PY - 2014 DA - 2014// TI - Imatinib in Scleroderma Italian Study Group. Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study JO - Arthritis Res Ther. VL - 16 UR - https://doi.org/10.1186/ar4606 DO - 10.1186/ar4606 ID - Fraticelli2014 ER -